Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?
出版年份 2016 全文链接
标题
Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 140, Issue 1, Pages 234-246
出版商
Wiley
发表日期
2016-09-12
DOI
10.1002/ijc.30425
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SZC015, a synthetic oleanolic acid derivative, induces both apoptosis and autophagy in MCF-7 breast cancer cells
- (2016) Jingjun Wu et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The Dietary Flavonoid Fisetin Causes Cell Cycle Arrest, Caspase-Dependent Apoptosis, and Enhanced Cytotoxicity of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
- (2016) Matthew L. Smith et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma
- (2015) David S H Liu et al. GUT
- Proteome-wide analysis of mutant p53 targets in breast cancer identifies new levels of gain-of-function that influence PARP, PCNA, and MCM4
- (2015) Alla Polotskaia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anticancer effects of tributyltin chloride and triphenyltin chloride in human breast cancer cell lines MCF-7 and MDA-MB-231
- (2015) Luba Hunakova et al. TUMOR BIOLOGY
- APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
- (2015) N Mohell et al. Cell Death & Disease
- Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers
- (2015) Pawel Domagala et al. PLoS One
- Using real-time impedance-based assays to monitor the effects of fibroblast-derived media on the adhesion, proliferation, migration and invasion of colon cancer cells
- (2014) Catríona M. Dowling et al. BIOSCIENCE REPORTS
- PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance
- (2014) B. Tessoulin et al. BLOOD
- p53 as a target for the treatment of cancer
- (2014) Michael J. Duffy et al. CANCER TREATMENT REVIEWS
- Modulation of the poly (ADP-ribose) polymerase inhibitor response and DNA recombination in breast cancer cells by drugs affecting endogenous wild-type p53
- (2014) Ivanildce Cristiane Ireno et al. CARCINOGENESIS
- New Strategies for Triple-Negative Breast Cancer--Deciphering the Heterogeneity
- (2014) I. A. Mayer et al. CLINICAL CANCER RESEARCH
- PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
- (2013) J.-m. Lee et al. ANNALS OF ONCOLOGY
- The Management of Early-Stage and Metastatic Triple-Negative Breast Cancer
- (2013) Carey K. Anders et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase
- (2013) X Peng et al. Cell Death & Disease
- ADAM-17: a novel therapeutic target for triple negative breast cancer
- (2012) P. M. McGowan et al. ANNALS OF ONCOLOGY
- Failure of Iniparib to Inhibit Poly(ADP-Ribose) Polymerase In Vitro
- (2012) A. G. Patel et al. CLINICAL CANCER RESEARCH
- Targeted therapy for triple-negative breast cancer: Where are we?
- (2012) Michael J. Duffy et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Multiple Stress Signals Activate Mutant p53 In Vivo
- (2011) Y.-A. Suh et al. CANCER RESEARCH
- Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a Bona Fide PARP Inhibitor
- (2011) X. Liu et al. CLINICAL CANCER RESEARCH
- PRIMA-1Met/APR-246 Induces Apoptosis and Tumor Growth Delay in Small Cell Lung Cancer Expressing Mutant p53
- (2011) R. Zandi et al. CLINICAL CANCER RESEARCH
- p53 and its mutants in tumor cell migration and invasion
- (2011) Patricia A. J. Muller et al. JOURNAL OF CELL BIOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors
- (2010) Yayun Liang et al. BREAST CANCER RESEARCH AND TREATMENT
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Reactivation of p53: from peptides to small molecules
- (2010) Christopher J. Brown et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis
- (2009) J M R Lambert et al. ONCOGENE
- Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity
- (2008) Linda Hughes et al. CLINICAL & EXPERIMENTAL METASTASIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started